The chief scientist Carl (American) studied at (Ivy League)Tufts University and MIT, has obtained multiple chemical and pharmaceutical engineering degree.
Gawryl, M. Clark, T., Rausch, C., “Characterization of highly purified polymerized bovine hemoglobin,” Red Cell Substitutes Proceedings, Second International Symposium of Red Cell Substitutes, ed Sekiguchi,S. 1991, Publisher: Kindai Shuppan, Ltd, p28
He worked as vice president of America Waters Company (one of the 500 Standard&Poors stock index ) from 1981 to 1984, he is also the joint inventor of high performance liquid chromatograph.
He was a co-founder of America BIOPURE Company and appointed as vice president and chief technology officer in 2002.
Mr. Carl was reported by world important medical magazines and media for multiple times because of his commitment to the ALTAPURETM platform research and successful development of high efficiency and high purity oxygen-carrying hemoglobin.
Redpharm has a group of farsighted scientists from different fields. Efficient, healthy and sustainable development of the enterprise is realized through integrating resources, increase its development and operation ability.
• President, Biodextris, Inc
• Director, New Product Development, GSK Vaccines (2005-2015)
• Protein purification development and manufacturiung
• cientist, academician, professor and clinical trial expert with a successful career in both the business and academic sides of cardiology and electrophysiology.
• Senior Scientist —Lawrence Berkeley NationalLaboratory
• Lawrence Berkeley National Laboratory.
• American Physical Society.
• URS GIGER, PD, DVM, MS
• University of Pennsylvania
• 30 years of extensive experience in the design, construction,process development,manufacturing and establishment of operation for biopharmaceutical facilities.
Redpharm innovatively integrates domestic and foreign excellent resources, develop diversified innovation research through strategic alliance and project cooperation, enhance team research and develop ability and try to forge the world class innovative biopharmacy development company.